Cosmos Pharmaceuticals
Middletown, US · Founded 2017 · Delaware corporation · 24 employees on LinkedIn · 1 known investors
Find your way into Cosmos Pharmaceuticals
279 people in our graph share verified history with the Cosmos Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.
Hannah Clarkunlockedknows Philip McBride · together at William & Mary (overlapped)
×4knows the team · via Massachusetts Institute of Technology
×7knows the team · via William & Mary
FortisKap makes a fingerprint-secured connected cap for standard prescription vials that logs who opens a medication, when, and how many pills remain, producing time-stamped adherence data. It is aimed at patients, families, and clinicians as well as care programs to track medication access, misuse, and diversion.
Founders & leadership
JW
Joseph W. WhiteinChief Innovation OfficerCo-founder and Chief Innovation Officer of Cosmos Pharmaceuticals, Joseph White holds a B.S. in Economics from the College of William & Mary and leads development of FortisKap, a connected medical device that monitors medication adherence and tracks prescription use patterns.
AM
Alexander M. ColtoninCEO at Cosmos Rx Inc.Alexander Colton is Founder and CEO of Cosmos Pharmaceuticals, which develops FortisKap, a connected prescription vial cap that tracks medication adherence. He holds degrees in Computational & Applied Mathematics & Statistics and Economics from the College of William & Mary.
PM
Philip McBrideinCEO at Cosmos Rx Inc.Philip McBride is an Engineering Lead at Cosmos Pharmaceuticals, which develops FortisKap, a fingerprint-secured connected cap for prescription vials that tracks medication adherence and monitors for misuse. He holds degrees in Computational & Applied Mathematics & Statistics and Economics from the College of William & Mary.
M
MelissainCommercialization Executive
A
AlexinTechnical Development Lead
NM
Nick MorseinClinical Lead
J
JoshinGrowth Strategy Lead
TK
Tanveer KanalainFinance & Market Strategy Lead
Board
BE
Bart EdmundsBoard director
CC
Christian ColtonBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 3 rounds · 2020–2025
▶$750KraisedOct 2025 · 14 investors · Other Health CareRule 506(b)
▶$750KraisedOct 2025 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph W. WhiteExecutive Officer, Director
- Alexander M. ColtonExecutive Officer, Director
- Philip McBrideExecutive Officer
- Bart EdmundsDirector
- Christian ColtonDirector
- Offering amount
- $1.3M
- Amount sold
- $750K
- Proceeds to insiders
- $550K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$175KraisedJun 2022 · 7 investors · Other Health CareRule 506(b)
▶$175KraisedJun 2022 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alexander M. ColtonExecutive Officer, Director
- Joseph W. WhiteExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $175K
- Minimum investment
- $10K
- First sale
- May 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$225KraisedFeb 2021 · 7 investors · Other Health CareRule 506(b)
▶$225KraisedFeb 2021 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph W. WhiteExecutive Officer, Director
- Alexander M. ColtonExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $225K
- Minimum investment
- $10K
- Proceeds to insiders
- $10K
- First sale
- Dec 2020
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cosmos Pharmaceuticals do?
- FortisKap makes a fingerprint-secured connected cap for standard prescription vials that logs who opens a medication, when, and how many pills remain, producing time-stamped adherence data. It is aimed at patients, families, and clinicians as well as care programs to track medication access, misuse, and diversion.
- Who are Cosmos Pharmaceuticals's investors?
- Cosmos Pharmaceuticals's investors include The Innovation Space.
- How much funding has Cosmos Pharmaceuticals raised?
- Cosmos Pharmaceuticals has disclosed $1.1M raised across 3 rounds.
- Where is Cosmos Pharmaceuticals headquartered?
- Cosmos Pharmaceuticals is headquartered in Middletown, US.